Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance
To better manage seasonal and pandemic influenza infections, new drugs are needed with enhanced activity against amantadine- and rimantadine-resistant…
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 2025
|
| In: |
Antiviral research
Year: 2025, Jahrgang: 236, Pages: 1-11 |
| ISSN: | 1872-9096 |
| DOI: | 10.1016/j.antiviral.2025.106104 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.antiviral.2025.106104 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0166354225000300 
|
| Verfasserangaben: | Ian Tietjen, Daniel C. Kwan, Annett Petrich, Roland Zell, Theodosia Antoniadou, Agni Gavriilidou, Christina Tzitzoglaki, Michail Rallis, David Fedida, Francesc X. Sureda, Cato Mestdagh, Lieve Naesens, Salvatore Chiantia, F. Brent Johnson, Antonios Kolocouris |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1940812933 | ||
| 003 | DE-627 | ||
| 005 | 20251111111128.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251111s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.antiviral.2025.106104 |2 doi | |
| 035 | |a (DE-627)1940812933 | ||
| 035 | |a (DE-599)KXP1940812933 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Tietjen, Ian |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance |c Ian Tietjen, Daniel C. Kwan, Annett Petrich, Roland Zell, Theodosia Antoniadou, Agni Gavriilidou, Christina Tzitzoglaki, Michail Rallis, David Fedida, Francesc X. Sureda, Cato Mestdagh, Lieve Naesens, Salvatore Chiantia, F. Brent Johnson, Antonios Kolocouris |
| 246 | 3 | 3 | |a Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2 S31N -based drug resistance |
| 264 | 1 | |c April 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist "S31N" hochgestellt | ||
| 500 | |a Online veröffentlicht: 11. Februar 2025, Artikelversion 17. Februar 2025 | ||
| 500 | |a Gesehen am 11.11.2025 | ||
| 520 | |a To better manage seasonal and pandemic influenza infections, new drugs are needed with enhanced activity against amantadine- and rimantadine-resistant… | ||
| 700 | 1 | |a Kwan, Daniel C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Petrich, Annett |e VerfasserIn |0 (DE-588)1313199966 |0 (DE-627)1873679602 |4 aut | |
| 700 | 1 | |a Zell, Roland |d 1958- |e VerfasserIn |0 (DE-588)124546013 |0 (DE-627)706660579 |0 (DE-576)294225269 |4 aut | |
| 700 | 1 | |a Antoniadou, Theodosia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gavriilidou, Agni Faviola Mika |d 1988- |e VerfasserIn |0 (DE-588)1161114696 |0 (DE-627)1024527212 |0 (DE-576)506364283 |4 aut | |
| 700 | 1 | |a Tzitzoglaki, Christina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rallis, Michail |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fedida, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sureda, Francesc X. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mestdagh, Cato |e VerfasserIn |4 aut | |
| 700 | 1 | |a Naesens, Lieve |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chiantia, Salvatore |e VerfasserIn |0 (DE-588)1147088527 |0 (DE-627)1008471534 |0 (DE-576)285186914 |4 aut | |
| 700 | 1 | |a Johnson, F. Brent |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kolocouris, Antonios |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antiviral research |d Amsterdam [u.a.] : Elsevier Science, 1981 |g 236(2025) vom: Apr., Artikel-ID 106104, Seite 1-11 |h Online-Ressource |w (DE-627)306311534 |w (DE-600)1495861-2 |w (DE-576)256113157 |x 1872-9096 |7 nnas |a Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance |
| 773 | 1 | 8 | |g volume:236 |g year:2025 |g month:04 |g elocationid:106104 |g pages:1-11 |g extent:11 |a Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.antiviral.2025.106104 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0166354225000300 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251111 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1313199966 |a Petrich, Annett |m 1313199966:Petrich, Annett |d 910000 |d 911700 |e 910000PP1313199966 |e 911700PP1313199966 |k 0/910000/ |k 1/910000/911700/ |p 3 | ||
| 999 | |a KXP-PPN1940812933 |e 4802051921 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance","title":"Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance"}],"person":[{"family":"Tietjen","given":"Ian","roleDisplay":"VerfasserIn","display":"Tietjen, Ian","role":"aut"},{"given":"Daniel C.","family":"Kwan","role":"aut","display":"Kwan, Daniel C.","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Petrich, Annett","given":"Annett","family":"Petrich"},{"display":"Zell, Roland","roleDisplay":"VerfasserIn","role":"aut","family":"Zell","given":"Roland"},{"family":"Antoniadou","given":"Theodosia","display":"Antoniadou, Theodosia","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Gavriilidou, Agni Faviola Mika","role":"aut","family":"Gavriilidou","given":"Agni Faviola Mika"},{"roleDisplay":"VerfasserIn","display":"Tzitzoglaki, Christina","role":"aut","family":"Tzitzoglaki","given":"Christina"},{"family":"Rallis","given":"Michail","roleDisplay":"VerfasserIn","display":"Rallis, Michail","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Fedida, David","given":"David","family":"Fedida"},{"given":"Francesc X.","family":"Sureda","role":"aut","roleDisplay":"VerfasserIn","display":"Sureda, Francesc X."},{"roleDisplay":"VerfasserIn","display":"Mestdagh, Cato","role":"aut","family":"Mestdagh","given":"Cato"},{"given":"Lieve","family":"Naesens","role":"aut","roleDisplay":"VerfasserIn","display":"Naesens, Lieve"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Chiantia, Salvatore","given":"Salvatore","family":"Chiantia"},{"display":"Johnson, F. Brent","roleDisplay":"VerfasserIn","role":"aut","family":"Johnson","given":"F. Brent"},{"roleDisplay":"VerfasserIn","display":"Kolocouris, Antonios","role":"aut","family":"Kolocouris","given":"Antonios"}],"titleAlt":[{"title":"Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2 S31N -based drug resistance"}],"language":["eng"],"recId":"1940812933","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Im Titel ist \"S31N\" hochgestellt","Online veröffentlicht: 11. Februar 2025, Artikelversion 17. Februar 2025","Gesehen am 11.11.2025"],"id":{"doi":["10.1016/j.antiviral.2025.106104"],"eki":["1940812933"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"April 2025"}],"name":{"displayForm":["Ian Tietjen, Daniel C. Kwan, Annett Petrich, Roland Zell, Theodosia Antoniadou, Agni Gavriilidou, Christina Tzitzoglaki, Michail Rallis, David Fedida, Francesc X. Sureda, Cato Mestdagh, Lieve Naesens, Salvatore Chiantia, F. Brent Johnson, Antonios Kolocouris"]},"relHost":[{"note":["Gesehen am 12.10.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistanceAntiviral research","recId":"306311534","corporate":[{"roleDisplay":"Herausgebendes Organ","display":"International Society for Antiviral Research","role":"isb"}],"language":["eng"],"pubHistory":["1.1981 -"],"part":{"volume":"236","text":"236(2025) vom: Apr., Artikel-ID 106104, Seite 1-11","extent":"11","year":"2025","pages":"1-11"},"title":[{"title":"Antiviral research","subtitle":"a multidisciplinary journal of antiviral agents, natural host defence mechanisms, interferons and antiviral vaccines ; an official publication of the International Society for Antiviral Research","title_sort":"Antiviral research"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1981-","publisher":"Elsevier Science","dateIssuedKey":"1981","publisherPlace":"Amsterdam [u.a.]"}],"id":{"zdb":["1495861-2"],"eki":["306311534"],"issn":["1872-9096"]}}],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen"}]} | ||
| SRT | |a TIETJENIANANTIVIRALM2025 | ||